Your new post is loading...
Your new post is loading...
|
Susan M. Baxter's curator insight,
July 22, 2013 7:11 PM
John Melo - Amyris' CEO - has a sweeping vision for his company's role in the biotechnology "ecosystem." |
by
Jenny Rooke
"Synthetic biology has the potential to contribute breakthrough innovations to the pursuit of new global health solutions. Wishing to harness the emerging tools of synthetic biology for the goals of global health, in 2011 the Bill & Melinda Gates Foundation put out a call for grant applications to “Apply Synthetic Biology to Global Health Challenges” under its “Grand Challenges Explorations” program. A highly diverse pool of over 700 applications was received. Proposed applications of synthetic biology to global health needs included interventions such as therapeutics, vaccines, and diagnostics, as well as strategies for biomanufacturing, and the design of tools and platforms that could further global health research."
http://bit.ly/13Vd6ge